Immuno-oncology is an emerging field in medicine that has the potential to radically change how cancer is treated.
As the patent cliff for many blockbuster biologic therapies is approaching, clinical development programs for biosimilar options to those therapies View product.
Diseases of the central nervous system (CNS) offer considerable opportunity to drug developers and marketers.
Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that could View product.
Pharmaceutical companies are attempting to maximize value from all angles, including internal investment in R&D and externalization via deal-making.
This Market Spotlight report covers the Cutaneous T-Cell Lymphoma (CTCL) market, comprising key pipeline and marketed drugs, clinical trials, upcoming View product.